Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gwo Xi Stem Cell Applied Technology Co Days Payable Chart
Gwo Xi Stem Cell Applied Technology Co Annual Data
ROCO:6704 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Gwo Xi Stem Cell Applied Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gwo Xi Stem Cell Applied Technology Co Days Payable vs Biotechnology Industry
Gwo Xi Stem Cell Applied Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) has a Days Payable of 51.98 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gwo Xi Stem Cell Applied Technology Co and its competitors. This is 39% above median its historical median of 37.39. Over the past decade, Gwo Xi Stem Cell Applied Technology Co's Days Payable has ranged from 0.42 to 53.01. According to the industry distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #488 out of 702 companies in the Biotechnology industry, placing it in the top 69.5%.
Is Gwo Xi Stem Cell Applied Technology Co's Days Payable too high?
Gwo Xi Stem Cell Applied Technology Co's current Days Payable of 51.98 is 39% above median its 10-year median of 37.39. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 53.01. The Biotechnology industry median Days Payable is 113.10. Gwo Xi Stem Cell Applied Technology Co's value of 51.98 is 54% below this industry median. Based on the distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #488 out of 702 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gwo Xi Stem Cell Applied Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gwo Xi Stem Cell Applied Technology Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #488 out of 702 companies for Days Payable. This places Gwo Xi Stem Cell Applied Technology Co in the lower half of its industry. The industry median Days Payable is 113.10. Gwo Xi Stem Cell Applied Technology Co's value of 51.98 is 54% below this benchmark. Historically, Gwo Xi Stem Cell Applied Technology Co's own Days Payable has ranged from 0.42 to 53.01 over the past decade. While the company's 10-year median is 37.39 vs. the industry median of 113.10, Gwo Xi Stem Cell Applied Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gwo Xi Stem Cell Applied Technology Co's current Days Payable of 51.98 is 54% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gwo Xi Stem Cell Applied Technology Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gwo Xi Stem Cell Applied Technology Co's current Days Payable is 51.98, which is 39% above median its own 10-year median of 37.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gwo Xi Stem Cell Applied Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) is currently considered Possible Value Trap. The stock's GF Value™ is NT$35.51, compared to a current price of NT$19.15 — trading 46.1% below its estimated fair value. The current Days Payable is 51.98, which is 39% above median its 10-year median of 37.39 and 54% below the Biotechnology industry median of 113.10. Gwo Xi Stem Cell Applied Technology Co's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Gwo Xi Stem Cell Applied Technology Co (ROCO:6704), the current Days Payable is 51.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) Overvalued in 2026?
Based on GuruFocus' analysis, Gwo Xi Stem Cell Applied Technology Co stock appears to be undervalued.
The current stock price of NT$19.15 is trading 46.1% below its estimated GF Value™ of NT$35.51.
GuruFocus considers Gwo Xi Stem Cell Applied Technology Co to be Possible Value Trap.
Key valuation signals for ROCO:6704:
Days Payable: 51.98 (39% above median its 10-year median of 37.39)
GF Value™: NT$35.51 vs. price of NT$19.15 (46.1% below fair value)
Industry Position: 54% below the Biotechnology median (#488 of 702)
No single metric tells the full story. See the ROCO:6704 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gwo Xi Stem Cell Applied Technology Co Business Description
Gwo Xi Stem Cell Applied Technology Co is committed to developing stem cell medicines that have the potential to help patients with unmet medical needs.
39GF Score
Get the complete analysis for ROCO:6704
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6704 has been successfully added to your 
